Rubicon Research Ltd.

Research Rubicon Research Ltd. (RUBICON.NS) on Bullrun: market cap INR 249.73B, P/E 86.9, dividend yield 0.1%. Explore financials, valuation history, model signals, and stock context.

Key Metrics

Valuation Snapshot

latest market cap is INR 249.73B; P/E is 86.9; dividend yield is 0.1%.

Peer valuation comparison

Latest P/E is 86.9x versus a Healthcare sector median of 21.74x (299.6% above).

Latest dividend yield is 0.1% versus a Healthcare sector median of 2.4% (95.8% below).

Valuation history

YearSnapshot dateMarket capP/EDividend yieldAnnual dividend/share
20262026-10-18INR 249.73B86.90.1%1.5

Dividend history

Latest trailing dividend snapshot: annual dividend/share 1.5 INR, yield 0.1%.

About Rubicon Research Ltd.

Rubicon Research Limited operates as a specialty pharmaceutical company in India, the United States, and internationally. The company develops products in the areas of analgesics/pain management, cardiovascular system, central nervous system, hypokalemia, skeletal muscle relaxants, nicotine replacement therapy, gastrointestinal, metabolic, and immunosuppressant.

Related stock research

India stocks India Healthcare stocks A-Z stock index

Other Healthcare stocks

Glaxosmithkline Pharmaceuticals Ltd. (GLAXO.NS) Abbott India Ltd. (ABBOTINDIA.NS) Ajanta Pharmaceuticals Ltd. (AJANTPHARM.NS) Alkem Laboratories Ltd. (ALKEM.NS) Anthem Biosciences Ltd. (ANTHEM.NS) Apollo Hospitals Enterprise Ltd. (APOLLOHOSP.NS) Aster DM Quality Care Ltd. (ASTERDM.NS) Aurobindo Pharma Ltd. (AUROPHARMA.NS) Biocon Ltd. (BIOCON.NS) Caplin Point Laboratories Ltd. (CAPLIPOINT.NS) Cipla Ltd. (CIPLA.NS) Cohance Lifesciences Ltd. (COHANCE.NS)

Frequently asked questions

What is Rubicon Research Ltd.'s market cap?

Rubicon Research Ltd.'s market capitalization is INR 249.73B.

What is Rubicon Research Ltd.'s P/E ratio?

Rubicon Research Ltd.'s price-to-earnings (P/E) ratio is 86.9.

Does Rubicon Research Ltd. pay a dividend?

Rubicon Research Ltd. has a dividend yield of 0.1%.

What does Rubicon Research Ltd. do?

Rubicon Research Limited operates as a specialty pharmaceutical company in India, the United States, and internationally. The company develops products in the areas of analgesics/pain management, cardiovascular system, central nervous system, hypokalemia, skeletal muscle relaxants, nicotine replacement therapy, gastrointestinal, metabolic, and immunosuppressant.